Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

6526–6550 of 18015

SevereFDA (Drugs)·D-0957-2020·2020-03-11
Axia Pharmaceutical Recalls Hydroxocobalamin Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Hydroxocobalamin Injection due to a lack of assurance of sterility. The affected product is distributed nationwide and in several international locations.
Product
Hydroxocobalamin Injection, HYDROXOCOBALAMIN 5MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0339-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0947-2020·2020-03-11
Axia Pharmaceutical Recalls Coenzyme Q10 Injection Due to Sterility Concerns
Fusion IV Pharmaceuticals is recalling Coenzyme Q10 Injection due to a lack of assurance of sterility. The product was distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Coenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0411-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0994-2020·2020-03-11
Axia Pharmaceutical Recalls Zinc Chloride Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Zinc Chloride Injection because the product lacks assurance of sterility.
Product
Zinc Chloride Injection, ZINC CHLORIDE 10MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0224-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0945-2020·2020-03-11
Axia Pharmaceutical Recalls Biotin Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling Biotin Injectable Suspension due to a lack of assurance of sterility. The product was distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Biotin (Vitamin H) Injectable Suspension, BIOTIN 10 MG/ML INJ SUSP, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0220-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0973-2020·2020-03-11
Axia Pharmaceutical Recalls MIC-B12 Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling MIC-B12 Injection because the product lacks assurance of sterility. The recall covers multiple lots distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
MIC-B12 Injection, MIC-B12 25MG/50MG/50MG/1MG/ML INJECTABLE, For IM Use, Refrigerate. Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0230-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0991-2020·2020-03-11
Axia Pharmaceutical Recalls Triamcinolone Diacetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Triamcinolone Diacetate Injectable Suspension because the product lacks assurance of sterility.
Product
Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE DIACETATE [10ML] CMC 80 MG/ML INJ SUSP, For IM, IA, IT Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0634-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0942-2020·2020-03-11
Axia Pharmaceutical Recalls Betamethasone Injectable Suspension Due to Sterility Concerns
Fusion IV Pharmaceuticals is recalling specific lots of Betamethasone Injectable Suspension because the company cannot guarantee the product is sterile.
Product
BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [2ML] 6MG/ML INJ SUSP, For IM, IA, IT Use, Shake Well. Preservative Free. Discard Unused Portion, 2 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. St
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0983-2020·2020-03-11
Axia Pharmaceutical Recalls Testosterone Cypionate Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Testosterone Cypionate Injection because the company cannot guarantee the product is sterile.
Product
Testosterone Cypionate Injection,TESTOSTERONE CYP IN GRAPESEED OIL [10ML] 200 MG/ML INJECTABLE, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0940-2020·2020-03-11
Axia Pharmaceutical Recalls AscorbiX Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling AscorbiX (Buffered C) Injection because the product lacks assurance of sterility. The recall covers specific lots distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-5
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0976-2020·2020-03-11
Axia Pharmaceutical Recalls Mitomycin-C Irrigation Solution Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Mitomycin-C Irrigation Solution because the FDA cannot assure the sterility of the product.
Product
Mitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use, Freeze, Cytoxic Agent, Preservative Free, Protect From Light, 80 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-081
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0989-2020·2020-03-11
Axia Pharmaceutical Recalls Triamcinolone Diacetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Triamcinolone Diacetate Injectable Suspension because the product lacks assurance of sterility.
Product
Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE Diacetate [10ML] CMC 10MG/ML INJ SUSP, For IM, IA Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0625-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0952-2020·2020-03-11
Axia Pharmaceutical Recalls Dexpanthenol Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Dexpanthenol Injection due to a lack of assurance of sterility. The affected lots were distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Dexpanthenol Injection, DEXPANTHENOL 250 MG/ML INJECTABLE, For IV, IM Use, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0214-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0937-2020·2020-03-11
Axia Pharmaceutical Recalls Alprostadil Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Alprostadil/Papaverine/Phentolamine Injection due to a lack of assurance of sterility. The product was distributed nationwide and in Puerto Rico, Barbados, and the Dominican Republic.
Product
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 20MCG/30MG/1MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0545-2
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0971-2020·2020-03-11
Axia Pharmaceutical Recalls Methylprednisolone Acetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Methylprednisolone Acetate Injectable Suspension because the product lacks assurance of sterility.
Product
Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0866-2020·2020-03-11
Lupin Recalls Desoximetasone Topical Spray Due to Impurity Failures
Lupin Pharmaceuticals is recalling 876 bottles of Desoximetasone Topical Spray because high out-of-specification impurities were detected.
Product
Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD
Category
Drug
Distribution
0 states
SevereFDA (Drugs)·D-0954-2020·2020-03-11
Axia Pharmaceutical Recalls Glycerin Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Glycerin (PF) Injection due to a lack of assurance of sterility. The affected product is distributed nationwide and in several international locations.
Product
Glycerin (PF) Injection,GLYCERIN 99% INJECTABLE, For IV Use,10 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0464-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0980-2020·2020-03-11
Axia Pharmaceutical Recalls Pyridoxine Hydrochloride Injection Due to Sterility Concerns
Fusion IV Pharmaceuticals is recalling specific lots of Pyridoxine Hydrochloride Injection due to a lack of assurance of sterility. The product was distributed nationwide and in several Caribbean territories.
Product
Pyridoxine Hydrochloride Injection, PYRIDOXINE HCL 100 MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0216-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0934-2020·2020-03-11
Axia Pharmaceutical Recalls Alprostadil Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Alprostadil/Papaverine/Phentolamine/Atropine Injection due to a lack of assurance of sterility. The product is distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30 mg/2 mg/0.15mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0550-2
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0935-2020·2020-03-11
Axia Pharmaceutical Recalls Alprostadil Injectable Due to Sterility Concerns
Axia Pharmaceutical is recalling Alprostadil injectable vials due to a lack of assurance of sterility. The affected product is distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Alprostadil (prostaglandin E1)150 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0538-2
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0986-2020·2020-03-11
Recall of Triamcinolone Acetonide/Bupivacaine Injectable Suspension Due to Sterility Concerns
FDA recalls Triamcinolone Acetonide/Bupivacaine Injectable Suspension due to lack of sterility assurance. The drug was distributed nationwide and in Puerto Rico, Barbados, and the Dominican Republic.
Product
Triamcinolone Acetonide/Bupivacaine Hydrochloride Injectable Suspension, TRIAMCINOLONE ACET/BUPIVACAINE HCL [10ML] 40MG/5MG/ML INJ SUSP, For IM, IA Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0632-1
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0967-2020·2020-03-11
Axia Pharmaceutical Recalls Methylcobalamin Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Methylcobalamin Injection because the product lacks assurance of sterility. The recall covers distribution in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0984-2020·2020-03-11
Axia Pharmaceutical Recalls Testosterone Cypionate Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Testosterone Cypionate Injection because the product lacks assurance of sterility. The recall covers specific lots distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Testosterone Cypionate Injection, TESTOSTERONE CYP IN GRAPESEED OIL [1ML] 200 MG/ML INJECTABLE, For IM Use, 1 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-2
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0862-2020·2020-03-11
Teva Recalls Mesalamine Tablets Due to Dissolution Test Failures
Teva Pharmaceuticals USA is recalling 3,695 bottles of Mesalamine Delayed-Release Tablets because stability testing showed low dissolution results.
Product
MESALAMINE — MESALAMINE (MESALAMINE)
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0964-2020·2020-03-11
Axia Pharmaceutical Recalls Magnesium Chloride Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Magnesium Chloride Injection because the company cannot assure the product's sterility.
Product
Magnesium Chloride Injection, MAGNESIUM CHLORIDE 20% INJECTABLE, For IV Use, 50 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0225-5
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0868-2020·2020-03-11
AAA Pharmaceutical Recalls Fexofenadine Tablets for Labeling Errors
AAA Pharmaceutical, Inc. is recalling specific lots of Discount Drug Mart Fexofenadine Hydrochloride Tablets due to incorrect or missing lot and expiration dates.
Product
Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bottle, NDC 53943-192-04, UPC Code 0-93351-03069-7; b) 45 tablets per bottle, NDC 53943-192-06, UPC Code 0-93351-03070-3, Distribute
Category
Drug
Distribution
1 state

How to read this listing

Filters

6526–6550 of 18015